Metoprolol PCD Pharma Franchise Company
Cafoli Lifecare provides a focused cardiac portfolio built around Metoprolol, with 20 formulations available as tablets and injection. All products are manufactured at WHO-GMP certified facilities and offered to PCD franchise partners on a monopoly basis.
What is Metoprolol?
Metoprolol is a cardioselective beta-1 adrenergic blocker. By blocking beta-1 receptors in the heart it reduces heart rate, contractility and cardiac output, thereby lowering blood pressure and myocardial oxygen demand. Further details are available on MedlinePlus.
Therapeutic Applications
Metoprolol is used in hypertension, angina pectoris, post-myocardial-infarction care, chronic heart failure and certain arrhythmias, and is also used for migraine prophylaxis. Key prescribers are cardiologists, consultant physicians and neurologists.
Why Metoprolol is a High-Potential Molecule for Distributors
Cardiovascular disease is India's leading cause of mortality, and beta-blockers remain a guideline-recommended pillar of long-term management. Metoprolol therapy is typically lifelong, generating dependable monthly refills, while the injectable presentation opens up hospital and emergency-care supply alongside the retail chemist channel.
Why Choose Cafoli Lifecare
We offer district-wise monopoly rights, WHO-GMP certified production, DCGI-approved formulations, attractive net rates and complete promotional inputs, supported by 1000+ franchise partners across India.
References
- MedlinePlus: Metoprolol
- PubChem: Metoprolol
- WHO Essential Medicines List
Our formulations of Metoprolol find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: